Ratings UniCredit S.p.A. Xetra

Equities

CRIN

IT0005239360

Market Closed - Xetra 11:35:31 2024-06-28 EDT 5-day change 1st Jan Change
34.6 EUR +0.07% Intraday chart for UniCredit S.p.A. +2.11% +40.74%

Strengths

  • Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
  • Its low valuation, with P/E ratio at 6.39 and 6.17 for the ongoing fiscal year and 2025 respectively, makes the stock pretty attractive with regard to earnings multiples.
  • The company appears to be poorly valued given its net asset value.
  • This company will be of major interest to investors in search of a high dividend stock.
  • Over the past year, analysts have regularly revised upwards their sales forecast for the company.
  • Over the last 4 months, analysts have significantly revised upwards the company's estimated sales.
  • For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
  • Analysts remain confident with respect to the group's activity and, more often than not, have revised upwards their earnings per share estimates.
  • Analysts covering this company mostly recommend stock overweighting or purchase.
  • The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
  • Over the past four months, analysts' average price target has been revised upwards significantly.
  • Historically, the company has been releasing figures that are above expectations.

Weaknesses

  • As estimated by analysts, this group is among those businesses with the lowest growth prospects.
  • Over the past twelve months, analysts' consensus has been significantly revised downwards.

Ratings chart - Surperformance

Sector: Banks

1st Jan change Capi. Investor Rating ESG Refinitiv
+40.74% 59.52B -
+18.91% 581B
C+
+18.12% 311B
C+
+21.47% 263B
C+
+24.09% 187B
B-
+29.19% 175B
B-
+7.62% 158B
C+
-1.49% 154B
B-
+8.69% 150B
B-
+13.94% 142B
C+
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
-
Profitability
Finances
-

Valuation

P/E ratio
EV / Sales
-
Price to Book
Price to Free Cash Flow
-
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes